Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001209191-14-065651

President acquired 96,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCOTT TIMOTHY PHD President 2014-10-29 Option exercise +96,875 $0.64 $62,000 1,521,845 D
Derivatives
SCOTT TIMOTHY PHD President 2014-10-29 Option exercise · Stock Option (right to buy) −96,875 203,125 D
Loading xslF345X03/doc4.xml…